Logo image of SGMO

SANGAMO THERAPEUTICS INC (SGMO) Stock News

NASDAQ:SGMO - Nasdaq - US8006771062 - Common Stock - Currency: USD

0.4733  -0.02 (-4.29%)

After market: 0.4781 +0 (+1.01%)

SGMO Latest News, Press Relases and Analysis

News Image
11 days ago - Chartmill

These stocks are moving in today's session

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Mentions: NCL BGFV AXDX AFMD ...

News Image
11 days ago - Chartmill

Tuesday's session: top gainers and losers

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Mentions: NCL RGC DDD TLYS ...

News Image
11 days ago - Chartmill

There are notable gap-ups and gap-downs in today's session.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Mentions: HALO ARRY TBI DDD ...

News Image
11 days ago - Chartmill

Which stocks are moving before the opening bell on Tuesday?

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Mentions: CHRS DDD ARCT AXDX ...

News Image
12 days ago - Zacks Investment Research

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates

Sangamo (SGMO) delivered earnings and revenue surprises of -27.27% and 29.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: ARMP

News Image
12 days ago - Chartmill

Which stocks are moving after the closing bell on Monday?

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Mentions: ARWR MVIS DGLY ARCT ...

News Image
16 days ago - Zacks Investment Research

Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates

Novavax (NVAX) delivered earnings and revenue surprises of 312.68% and 215.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: NVAX

News Image
19 days ago - Zacks Investment Research

Regenxbio (RGNX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Regenxbio (RGNX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mentions: RGNX

News Image
23 days ago - Zacks Investment Research

Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Sangamo (SGMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mentions: QGEN

News Image
2 months ago - Stocktwits

Eli Lilly Stock Drops As Trump Tariff Chaos Hits Markets, But Retail Finds Comfort In Big Pharma’s Exemption

On Stocktwits, message volume about Lilly jumped by 23% over the past 24 hours, with retail sentiment turning more ‘bullish.’

Mentions: LLY XLV

News Image
2 months ago - Stocktwits

Sangamo Therapeutics Retail Traders Keep The Faith Even As Stock Slides After-Hours On Q4 Miss

Several optimistic users expressed confidence in the company securing a third potential agreement with a major pharma for its adeno-associated virus (AAV) capsid, STAC-BBB.

Mentions: VTI XBI SCHA